Clostridium Botulinum Infection Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: CB9A4B5EED8CEN
Market Monitor Global

Abstracts

Clostridium botulinum infections are caused by clostridium botulinum, a gram-positive, rod-shaped bacterium which produces an extremely lethal substance that is botulism neurotoxin.

This report contains market size and forecasts of Clostridium Botulinum Infection Treatment in Global, including the following market information:

Global Clostridium Botulinum Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Clostridium Botulinum Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antitoxin Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Clostridium Botulinum Infection Treatment include DynPort Vaccine, Emergent BioSolutions, AlphaVax, Emergent BioSolutions and Morphotek, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clostridium Botulinum Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Clostridium Botulinum Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Clostridium Botulinum Infection Treatment Market Segment Percentages, by Type, 2021 (%)

• Antitoxin Therapy
• Meticulous Airway Management
• Mechanical Breathing Assistance

Global Clostridium Botulinum Infection Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Clostridium Botulinum Infection Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Clostridium Botulinum Infection Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Clostridium Botulinum Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Clostridium Botulinum Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Clostridium Botulinum Infection Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• DynPort Vaccine
• Emergent BioSolutions
• AlphaVax
• Emergent BioSolutions
• Morphotek

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Clostridium Botulinum Infection Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Clostridium Botulinum Infection Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CLOSTRIDIUM BOTULINUM INFECTION TREATMENT OVERALL MARKET SIZE

2.1 Global Clostridium Botulinum Infection Treatment Market Size: 2021 VS 2028
2.2 Global Clostridium Botulinum Infection Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Clostridium Botulinum Infection Treatment Players in Global Market
3.2 Top Global Clostridium Botulinum Infection Treatment Companies Ranked by Revenue
3.3 Global Clostridium Botulinum Infection Treatment Revenue by Companies
3.4 Top 3 and Top 5 Clostridium Botulinum Infection Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Clostridium Botulinum Infection Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clostridium Botulinum Infection Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Clostridium Botulinum Infection Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Clostridium Botulinum Infection Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Clostridium Botulinum Infection Treatment Market Size Markets, 2021 & 2028
  4.1.2 Antitoxin Therapy
  4.1.3 Meticulous Airway Management
  4.1.4 Mechanical Breathing Assistance
4.2 By Type - Global Clostridium Botulinum Infection Treatment Revenue & Forecasts
  4.2.1 By Type - Global Clostridium Botulinum Infection Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Clostridium Botulinum Infection Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Clostridium Botulinum Infection Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Clostridium Botulinum Infection Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Clostridium Botulinum Infection Treatment Revenue & Forecasts
  5.2.1 By Application - Global Clostridium Botulinum Infection Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Clostridium Botulinum Infection Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Clostridium Botulinum Infection Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Clostridium Botulinum Infection Treatment Market Size, 2021 & 2028
6.2 By Region - Global Clostridium Botulinum Infection Treatment Revenue & Forecasts
  6.2.1 By Region - Global Clostridium Botulinum Infection Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Clostridium Botulinum Infection Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Clostridium Botulinum Infection Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Clostridium Botulinum Infection Treatment Revenue, 2017-2028
  6.3.2 US Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.3.3 Canada Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.3.4 Mexico Clostridium Botulinum Infection Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Clostridium Botulinum Infection Treatment Revenue, 2017-2028
  6.4.2 Germany Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.4.3 France Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.4.4 U.K. Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.4.5 Italy Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.4.6 Russia Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.4.8 Benelux Clostridium Botulinum Infection Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Clostridium Botulinum Infection Treatment Revenue, 2017-2028
  6.5.2 China Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.5.3 Japan Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.5.4 South Korea Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.5.6 India Clostridium Botulinum Infection Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Clostridium Botulinum Infection Treatment Revenue, 2017-2028
  6.6.2 Brazil Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.6.3 Argentina Clostridium Botulinum Infection Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Clostridium Botulinum Infection Treatment Revenue, 2017-2028
  6.7.2 Turkey Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.7.3 Israel Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Clostridium Botulinum Infection Treatment Market Size, 2017-2028
  6.7.5 UAE Clostridium Botulinum Infection Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 DynPort Vaccine
  7.1.1 DynPort Vaccine Corporate Summary
  7.1.2 DynPort Vaccine Business Overview
  7.1.3 DynPort Vaccine Clostridium Botulinum Infection Treatment Major Product Offerings
  7.1.4 DynPort Vaccine Clostridium Botulinum Infection Treatment Revenue in Global Market (2017-2022)
  7.1.5 DynPort Vaccine Key News
7.2 Emergent BioSolutions
  7.2.1 Emergent BioSolutions Corporate Summary
  7.2.2 Emergent BioSolutions Business Overview
  7.2.3 Emergent BioSolutions Clostridium Botulinum Infection Treatment Major Product Offerings
  7.2.4 Emergent BioSolutions Clostridium Botulinum Infection Treatment Revenue in Global Market (2017-2022)
  7.2.5 Emergent BioSolutions Key News
7.3 AlphaVax
  7.3.1 AlphaVax Corporate Summary
  7.3.2 AlphaVax Business Overview
  7.3.3 AlphaVax Clostridium Botulinum Infection Treatment Major Product Offerings
  7.3.4 AlphaVax Clostridium Botulinum Infection Treatment Revenue in Global Market (2017-2022)
  7.3.5 AlphaVax Key News
7.4 Emergent BioSolutions
  7.4.1 Emergent BioSolutions Corporate Summary
  7.4.2 Emergent BioSolutions Business Overview
  7.4.3 Emergent BioSolutions Clostridium Botulinum Infection Treatment Major Product Offerings
  7.4.4 Emergent BioSolutions Clostridium Botulinum Infection Treatment Revenue in Global Market (2017-2022)
  7.4.5 Emergent BioSolutions Key News
7.5 Morphotek
  7.5.1 Morphotek Corporate Summary
  7.5.2 Morphotek Business Overview
  7.5.3 Morphotek Clostridium Botulinum Infection Treatment Major Product Offerings
  7.5.4 Morphotek Clostridium Botulinum Infection Treatment Revenue in Global Market (2017-2022)
  7.5.5 Morphotek Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Clostridium Botulinum Infection Treatment Market Opportunities & Trends in Global Market
Table 2. Clostridium Botulinum Infection Treatment Market Drivers in Global Market
Table 3. Clostridium Botulinum Infection Treatment Market Restraints in Global Market
Table 4. Key Players of Clostridium Botulinum Infection Treatment in Global Market
Table 5. Top Clostridium Botulinum Infection Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Clostridium Botulinum Infection Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Clostridium Botulinum Infection Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Clostridium Botulinum Infection Treatment Product Type
Table 9. List of Global Tier 1 Clostridium Botulinum Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Clostridium Botulinum Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Clostridium Botulinum Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Clostridium Botulinum Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Clostridium Botulinum Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Clostridium Botulinum Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Clostridium Botulinum Infection Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Clostridium Botulinum Infection Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 30. DynPort Vaccine Corporate Summary
Table 31. DynPort Vaccine Clostridium Botulinum Infection Treatment Product Offerings
Table 32. DynPort Vaccine Clostridium Botulinum Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Emergent BioSolutions Corporate Summary
Table 34. Emergent BioSolutions Clostridium Botulinum Infection Treatment Product Offerings
Table 35. Emergent BioSolutions Clostridium Botulinum Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 36. AlphaVax Corporate Summary
Table 37. AlphaVax Clostridium Botulinum Infection Treatment Product Offerings
Table 38. AlphaVax Clostridium Botulinum Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Emergent BioSolutions Corporate Summary
Table 40. Emergent BioSolutions Clostridium Botulinum Infection Treatment Product Offerings
Table 41. Emergent BioSolutions Clostridium Botulinum Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Morphotek Corporate Summary
Table 43. Morphotek Clostridium Botulinum Infection Treatment Product Offerings
Table 44. Morphotek Clostridium Botulinum Infection Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Clostridium Botulinum Infection Treatment Segment by Type in 2021
Figure 2. Clostridium Botulinum Infection Treatment Segment by Application in 2021
Figure 3. Global Clostridium Botulinum Infection Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Clostridium Botulinum Infection Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Clostridium Botulinum Infection Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Clostridium Botulinum Infection Treatment Revenue in 2021
Figure 8. By Type - Global Clostridium Botulinum Infection Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Clostridium Botulinum Infection Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Clostridium Botulinum Infection Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Clostridium Botulinum Infection Treatment Revenue Market Share, 2017-2028
Figure 12. US Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Clostridium Botulinum Infection Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Clostridium Botulinum Infection Treatment Revenue Market Share, 2017-2028
Figure 24. China Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Clostridium Botulinum Infection Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Clostridium Botulinum Infection Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Clostridium Botulinum Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. DynPort Vaccine Clostridium Botulinum Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Emergent BioSolutions Clostridium Botulinum Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AlphaVax Clostridium Botulinum Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Emergent BioSolutions Clostridium Botulinum Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Morphotek Clostridium Botulinum Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)